Ahmed Galal, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas (NCT03920631) | Ahmed Galal, MD | 2020-07-10 |
Track Ahmed Galal, MD automatically
Every clearance here is in the API, with alerts when new ones post.